Clinical Trial Update: AB-1002 in Patients With Class III Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for AB-1002 in patients with class III heart failure; study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• AB-1002

Snippet

Sponsor: AskBio Inc | Conditions: Congestive Heart Failure, Heart Failure | Phase 1 | Status: ACTIVE_NOT_RECRUITING